Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
La Radiologia Medica|March 21, 2025
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteriaCharlotte Trombadori, Edda Boccia, Elena Huong Tran, et al.
Critical Reviews in Oncology/Hematology|July 8, 2024
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2Alessandra Fabi, Laura Cortesi, Simona Duranti, et al.
Cancers|March 10, 2022
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center ExperienceAlba Di Leone, Antonio Franco, Daniela Andreina Terribile, et al.
Journal of Personalized Medicine|August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast CancerFabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohortFabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
Journal of Personalized Medicine|March 6, 2021
The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer-ATTM.BLADEFabio Marazzi, Valeria Masiello, Carlotta Masciocchi, et al.
Journal of Personalized Medicine|August 25, 2023
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant ChemotherapyAntonio Franco, Alba Di Leone, Marco Conti, et al.
Future Oncology (London, England)|June 14, 2025
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK studyFranco Antonio, Luisa Carbognin, Ida Paris, et al.
Cancers|December 30, 2025
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary CohortElena Jane Mason, Alba Di Leone, Beatrice Carnassale, et al.
NPJ Breast Cancer|February 5, 2025
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Giovanna Garufi, Giulia Giordano, et al.
Pageof 6